Concepedia

NamPhuong Tran

NT

Statistics

Publications

4

Citations

3.4K

H-Index

4

Active since

2014

Affiliations

Janssen (United States)(Current)

Université Paris-Sud

Instituto de Oncología de Rosario

NamPhuong Tran is an author at Janssen (United States) specializing in prostate cancer, oncology, and urologic oncology.

Publications per year

2014–2019

4

Publications

4

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Karim Fizazi, NamPhuong Tran, Luis Fein et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

Karim Fizazi, NamPhuong Tran, Luis Fein et al. · The Lancet Oncology · 2019 · 813 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

Mary-Ellen Taplin, Bruce Montgomery, Christopher J. Logothetis et al. · Journal of Clinical Oncology · 2014 · 281 citations · Full text

Medicine, Oncology, Urology +17

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone

Eleni Efstathiou, John W. Davis, Louis L. Pisters et al. · European Urology · 2019 · 83 citations · Full text

Medicine, Oncology, Urology +17

1–4 of 4